Results 11 to 20 of about 20,680 (257)

Comparative Efficacy of Different Pharmacological Treatments for Pityriasis Rosea: A Network Meta-Analysis. [PDF]

open access: yesJ Clin Med
Background/Objectives: Pityriasis rosea (PR) is a self-limiting exanthematous disease associated with the endogenous reactivation of human herpesviruses (HHV)-6 and HHV-7. Classically, the lesions gradually resolve, leaving no sequelae.
Ciccarese G   +6 more
europepmc   +2 more sources

A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination. [PDF]

open access: yesCureus, 2023
Pityriasis rosea (PR) is an acute exanthematous disease, commonly preceded by a primary solitary herald patch followed by the onset of smaller scaly papulosquamous lesions within days to weeks.
Wong N   +4 more
europepmc   +2 more sources

Pityriasis Rosea-Like Eruption following anti-fatigue traditional herbs: Aconitum carmichaelii Debx and Panax Ginseng suspected. [PDF]

open access: yesBMC Complement Med Ther
Traditional herbs have a history of clinical use in anti-fatigue. However, several adverse effects of herbs have been identified. Pityriasis rosea-like eruption (PR-LE) is a rare cutaneous complication of herbs.
Zeng X   +7 more
europepmc   +2 more sources

Atypical Rash as a Presentation of Pityriasis Rosea in a 23-Month-Old. [PDF]

open access: yesCureus
Pityriasis rosea is a self-limiting skin disorder that can occur in pediatric patients. We report an atypical presentation of a 23-month-old male with a generalized rash similar in appearance to pityriasis rosea.
Tilak K, Ray E, Joseph M.
europepmc   +2 more sources

Pityriasis Rosea With Multiple Herald Patches Resulting in a V-shaped Pattern and a Christmas Tree Distribution. [PDF]

open access: yesCureus
Pityriasis rosea (PR), a benign and self-limiting skin disorder, typically manifests as a single initial lesion known as the herald patch. The herald patch is commonly followed by the development of secondary erythematous papules and plaques, aligning ...
Oya K, Ishii Y, Anju K, Nomura T.
europepmc   +2 more sources

Dermoscopy for the Differentiation of Subacute Cutaneous Lupus Erythematosus from Other Erythematous Desquamative Dermatoses-Psoriasis, Nummular Eczema, Mycosis Fungoides and Pityriasis Rosea. [PDF]

open access: yesJ Clin Med
Subacute cutaneous lupus erythematosus (SCLE) is a condition that might pose a diagnostic challenge. The aim of this study was to assess the usefulness of videodermoscopy in the differentiation of SCLE from other erythematous-desquamative dermatoses ...
Żychowska M, Kołcz K.
europepmc   +2 more sources

Pityriasis rosea in pregnancy: A case series and literature review. [PDF]

open access: yesJ Dtsch Dermatol Ges, 2022
Pityriasis rosea (PR), a common skin disease in young adults, may adversely affects the course of pregnancy and the unborn child.
Wenger-Oehn L   +6 more
europepmc   +2 more sources

A Rare Concurrence of Polymorphic Pityriasis Rosea: Two Atypical Variants Along with a Classical Plaque Variant in the Pediatric Age Group

open access: yesIndian Journal of Paediatric Dermatology
Pityriasis rosea, is an acute self-limiting papulosquamous inflammatory disorder. It usually starts with a herald patch on the trunk and proximal extremities, followed by scaly oval patches that give them a “Christmas tree” appearance. The lesions may be
Vidya Yadav   +4 more
doaj   +2 more sources

The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations. [PDF]

open access: yesDermatol Ther, 2022
The article by Martora F. et al. on a series of patients with pityriasis rosea (PR) after Moderna COVID-19 vaccine 1 recently published in your journal prompted us to make some observations.
Ciccarese G, Parodi A, Drago F.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy